Please login to the form below

norovirus

This page shows the latest norovirus news and features for those working in and with pharma, biotech and healthcare.

Takeda starts trial of norovirus vaccine

Takeda starts trial of norovirus vaccine. If approved the drug is anticipated to surpass sales of GSK’ s Rotarix vaccine. ... There is no drug treatment available, so management of norovirus focuses on preventing transmission and supportive care for

Latest news

Takeda pays $60m for vaccine company LigoCyte

Takeda pays $60m for vaccine company LigoCyte. Gains first-in-class norovirus candidate and new vaccine platform. ... Norovirus is responsible for a significant burden of disease around the world and is notoriously difficult to control.
Germinating virologists

The aim is to exploit the expertise he has built up in generating Naked Scientist to increase public knowledge in microbiology on issues such as C difficile, norovirus and MRSA.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Pharma deals during October 2012

LigoCyte has a number of vaccine products in development, including its lead candidate, which is in phase I/II vaccine to prevent norovirus gastroenteritis, commonly known as winter vomiting disease.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Takeda appoints head of vaccines development

Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Medical Writer, MedComms Agency: Salary TBC

Sudler London - Account Director: Competitive

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Medical Writer: Salary is DOE

Healthcare PR Senior Account Manager: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Systematic Review Lead- London: Negotiable

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Graduate Scientific Editor: DOE

Account Manager- 4 days per week or full-time: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Account Manager: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Sudler London - Senior Medical Writer: Competitive

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Medical Writer - Creative and Scientific Projects: DOE

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Subscribe to our email news alerts

PMHub

Add my company

Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....